| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | VISA INC | 8,320,846 | 688,134,000 | 8.20% | ||
| 2 | FACEBOOK INC | 4,622,813 | 592,968,000 | 7.06% | ||
| 3 | ALPHABET INC | 740,384 | 575,493,000 | 6.86% | ||
| 4 | NIKE INC | 9,843,582 | 518,265,000 | 6.17% | ||
| 5 | PRICELINE GRP INC | 342,149 | 503,469,000 | 6.00% | ||
| 6 | STARBUCKS CORP | 9,022,392 | 488,472,000 | 5.82% | ||
| 7 | ACCENTURE PLC IRELAND | 3,787,777 | 462,753,000 | 5.51% | ||
| 8 | ADOBE INC | 3,964,016 | 430,254,000 | 5.13% | ||
| 9 | TJX COS INC NEW | 5,748,367 | 429,863,000 | 5.12% | ||
| 10 | ORACLE CORP | 10,133,372 | 398,039,000 | 4.74% | ||
| 11 | AUTOMATIC DATA PROCESSING IN | 4,507,960 | 397,602,000 | 4.74% | ||
| 12 | NESTLE SA SPONSORED ADR REPSTG | 4,917,942 | 388,350,000 | 4.63% | ||
| 13 | ALPHABET INC | 457,885 | 368,167,000 | 4.39% | ||
| 14 | O REILLY AUTOMOTIVE INC NEW | 1,297,688 | 363,495,000 | 4.33% | ||
| 15 | CELGENE CORP | 3,426,051 | 358,125,000 | 4.27% | ||
| 16 | APPLE INC | 2,982,582 | 337,181,000 | 4.02% | ||
| 17 | REGENERON PHARMACEUTICALS | 811,301 | 326,159,000 | 3.89% | ||
| 18 | GARTNER INC | 3,176,639 | 280,974,000 | 3.35% | ||
| 19 | MASTERCARD INCORPORATED | 1,777,872 | 180,934,000 | 2.16% | ||
| 20 | ALIGN TECHNOLOGY INC | 1,741,340 | 163,251,000 | 1.95% | ||
| 21 | DOLLAR GEN CORP NEW | 1,773,731 | 124,143,000 | 1.48% | ||
| 22 | ISHARES TR | 119,716 | 12,471,000 | 0.15% | ||
| 23 | ALIBABA GROUP HLDG LTD | 11,535 | 1,220,000 | 0.01% | ||
| 24 | CHECK POINT SOFTWARE TECH LT | 12,775 | 991,000 | 0.01% | ||
| 25 | FASTENAL CO | 23,480 | 981,000 | 0.01% | ||
| 26 | BAIDU INC | 5,013 | 913,000 | 0.01% | ||
| 27 | NOVO-NORDISK A S | 14,050 | 584,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001456511-16-000012, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
